Navigation Links
Vitamin Shots to Combat MS Pain

A recent study has revealed that vitamin shots may be beneficial in preventing severe long-term disability in multiple sclerosis patients.//

Presently there exists no effective treatment for the chronic progressive phase of MS, when serious disability is most likely to appear.

The Children's Hospital Boston study appearing in the Journal of Neuroscience, and conducted in mice showed that giving them a type of vitamin B3 known as nicotinamide cut the risk of nerve degeneration in mice with MS-type symptoms.

About 85,000 people in the UK, suffer from MS which is a disease of the central nervous system. The symptoms begin with the break down of the myelin sheath that coats nerve fibers, disrupting the ability to conduct electrical impulses to and from the brain.

Patients usually develop a form of the disease called relapsing-remitting MS, where outs of illness are followed by complete or partial recovery during which stage anti-inflammatory drugs can help.

However this stage is often followed by the chronic progressive phase, at which stage no effective treatment has been found.

The Boston team worked on mice with an MS-like disease called experimental autoimmune encephalitis (EAE).

The study revealed that daily nicotinamide shots protected the animals' nerve cells from myelin loss, stabilizing the condition of those cells that had already been affected. It was found that the greater the dose of nicotinamide, the greater the protective effect.

Rating disability on a scale of one to five, mice receiving the highest doses of nicotinamide scored between one and two, while animals who received no shots at all scored between three and four.

It was found that nicotinamide boosted levels of nicotinamide adenine dinucleotide (NAD), a vital chemical, in the animals' nervous systems.

In addition Nicotinamide also significantly reduced neurological deficits even wh en treatment was delayed until 10 days after the induction of EAE - raising hope that it will also be effective in the later stages of MS. Lead researcher Dr Shinjiro Kaneko said: "The earlier therapy was started, the better the effect, but we hope nicotinamide can help patients who are already in the chronic stage."

According to the researchers nicotinamide was cheap, and was considered to have few side effects. However, they said further work was needed to test its effect on humans.

Simon Gillespie, chief executive of the MS Society, said: "Any potential treatment for reducing the chronic progression of disability in MS deserves pursuing.

"This is interesting early research which we should like to see developed, adding our usual caution that what works in mice does not always work in men."

A spokesperson for the MS Trust said: "These are interesting results, but studies in mice with the experimental equivalent of MS may not necessarily translate into a successful treatment for people with MS."

Vitamin shots may help protect multiple sclerosis patients from severe long-term disability, a study suggests.

Currently, there is no effective treatment for the chronic progressive phase of MS, when serious disability is most likely to appear.


Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Vitamins-The answer to Heart Disease?
3. Vitamin E, the latest warrior against diabetes
4. Vitamin Shields Brittle Bones
5. B Vitamin protects and lowers toxicity of Arthritis Drug
6. B Vitamin Supplementatoin Saves Money and Lives
7. Eat Vitamin C and stay young
8. Vitamin C for the heart
9. Vitamin B for Hepatitis
10. Vitamins reduce pre-eclampsia
11. Vitamin E useful for Alzheimers
Post Your Comments:

(Date:11/24/2015)... ... November 24, 2015 , ... In an article ... variables that determine which patients are or are not eligible for bariatric surgery. The ... BMI over 40, are more than 100 pounds overweight, or have a BMI of ...
(Date:11/24/2015)... ... 24, 2015 , ... It takes only three to five seconds to make ... the first impression be positive and reflects business values. If a client starts with ... want to return. They will also share their thoughts about a business with others, ...
(Date:11/24/2015)... ... 24, 2015 , ... Cancer patients, survivors, caregivers, family members ... live taping of the next CURE Connections® video series on Saturday, ... Symposium at Georgetown University Hotel & Conference Center in Washington, D.C. , CURE ...
(Date:11/24/2015)... ... November 24, 2015 , ... Aided by seed funding from the ... study designed to yield insights into how to detect and treat pancreatic cancer (PC). ... cancer from small, non-coding RNA molecules (ncRNA), genetic material that is present in the ...
(Date:11/24/2015)... ... 2015 , ... Sir Grout of Baltimore is proud to ... award recognizes good companies for excellence in service and a commitment to the ... surface restoration company earned this recognition after a thorough review by the acclaimed ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Connecticut , November 24, 2015 ... of Acadiana has entered into a multi-year agreement ... imaging centers. This investment will provide the Breast Center ... --> Sectra (STO: SECT B) announces that ... agreement to deploy Breast Imaging PACS in its ...
(Date:11/24/2015)... , Nov. 24, 2015  Ascendant Solutions, Inc. (Pink Sheets: ... its Board of Directors has declared a special 1 percent ... dividend is payable December 14, 2015, to shareholders of record ... form of additional shares of common stock. ... Board is a strong endorsement of our confidence in Ascendant,s ...
(Date:11/24/2015)... -- iRhythm Technologies, Inc. , a leading digital health care ... will participate in the 27th Annual Piper Jaffray Healthcare Conference at ... . Kevin King , Chief Executive Officer of ... 8:50am ET. --> --> ... . --> iRhythm is a privately held ...
Breaking Medicine Technology: